Loading
Viome Life Sciences secured $25 million in an internal Series D funding round. The round included participation from existing investors Khosla Ventures, Bold Capital, WRG Ventures, and Marc Benioff. This financing brought Viome's total raised capital to approximately $200 million.
Viome Life Sciences is a company focused on personalized health, offering at-home diagnostic tests for gut microbiome, oral health, and overall full-body health. The company utilizes artificial intelligence to analyze samples and provide personalized food and supplement recommendations. The new funds will be used to launch a new diagnostic division and expand its offerings in microbiome health and personalized health solutions, with a focus on early disease detection and preventative healthcare. Viome also appointed Kal Raman as its new chief operating officer to lead these initiatives.
Funding Round: Series D
Amount Raised: $25M
Valuation: Unknown
Lead Investor: Unknown
Other Funds that Invested: Khosla Ventures, Bold Capital, WRG Ventures, Marc Benioff
Company Industry: Health, Wellness & Fitness
Company Headquarters: Bellevue, Washington, United States
Join thousands of founders using our technology to find the right investors and close rounds faster than ever before.